About 2 Trademarks found for “ELVIUM LIFE SCIENCES ”

Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain

Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances

Pharmaceutical preparations, namely, pharmaceutical preparations for the relief of pain; pharmaceutical preparation, namely, bronchodilator; pharmaceutical preparations for the treatment of disorders of the eye; pharmaceutical preparations, namely, biopharmaceutical preparations, namely, biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; anti-emetic preparations; anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations, namely, anaesthetics for surgical use, general anaesthetics, inhalant anaesthetics, local anaesthetics, topical anaesthetics; inhalable anaesthetic, pre-anaesthetic and analgesic pharmaceutical preparations; bronchodilating pharmaceutical preparations; pharmaceutical preparations for the treatment of insomnia and sleep disorders; opioid antagonist pharmaceutical preparations; pharmaceutical preparations for the treatment of opioid overdose; nasal spray preparations; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders; pharmaceutical preparations for the treatment of nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy, cerebral palsy and multiple sclerosis; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; ophthalmic pharmaceutical preparations; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations for the treatment of anaphylactic reactions; drug delivery agents in the form of films that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoarthritic pain

Inhalers for therapeutic use; inhalers for medical purposes sold empty; medical devices and apparatus for the delivery of anaesthetic, pre-anaesthetic and analgesic substances